CeloNova Biosciences, operating under the ALTA Biomaterials brand, specializes in advanced polymer surface coating technologies aimed at enhancing the safety and performance of medical devices. Their flagship product, Polyzene-F (PzF) nanocoating, is characterized by its ultra-purity, elasticity, and high molecular weight, which contribute to its exceptional biocompatibility. This innovative coating serves as a barrier that minimizes thrombogenicity and inflammation, promoting rapid healing and reducing complications associated with medical implants. PzF is applicable to a variety of devices, including vascular implants, surgical meshes, and drug-eluting microspheres, making it a versatile solution for improving patient outcomes across multiple medical fields.

In addition to Polyzene-F, CeloNova has developed the Xero-Gel Drug-Coated PTCA Balloon, which features a bioactive coating designed for effective drug delivery in treating conditions like small vessel stenosis and restenosis. The company has also achieved commercial success with its COBRA PzF NanoCoated Coronary Stent, which allows for shorter dual antiplatelet therapy durations while maintaining safety and efficacy. Their Embozene™ and Tandem™ microspheres, both coated with PzF, are engineered to be biocompatible and minimize tissue reactions, further solidifying CeloNova's commitment to addressing complex clinical challenges in the medical technology industry.

United States

Alta Biomaterials is a biomedical company that specializes in design and development of proprietary coating and surface modification technologies for medical device OEMs.

CeloNova Biosciences (ALTA Biomaterials)

Company Details